-
-
-
-
-
-
-
U.S. biopharma earnings: Eli Lilly (LLY), Pfizer (PFE) take the stage
-
-
-
-
-
-
-
Lilly acquires three infectious disease companies for up to $3.83 billion
-
-
-
-
-
-
-
Lilly surges on earnings beat and raised guidance
-
-
-
-
-
-
-
The Longevity Trade Is No Longer a Buzzword — It's a $120 Billion Market, and the FDA Just Cleared the First Cellular Rejuvenation Trial
-
-
-
-
-
-
-
Should you buy the dip in Novo Nordisk stock? Wall Street analyst answers
-
-
-
-
-
-
-
Lilly to acquire Orna Therapeutics to advance cell therapies
-
-
-
-
-
-
-
This U.S. biotech stock is Bernstein's Top Pick for 2026
-
1,222,149 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

